Marie Neidert, 43, first started getting Botox about three years ago as a way to manage her migraines, but enjoyed the cosmetic side effects too. When the medspa she goes to switched to a different ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

The FDA has issued a warning about numerous adverse events, including hospitalizations, stemming from dosing errors and overdoses of compounded semaglutide injectable products, underscoring the risks ...